{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T03:46:39Z","timestamp":1775619999537,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T00:00:00Z","timestamp":1584576000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T00:00:00Z","timestamp":1584576000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Glutathione S-transferases play a key role in the detoxification of persistent oxidative stress products which are one of several risks factors that may be associated with many types of disease processes such as cancer, diabetes, and hypertension. In the present study, we characterize the null genotypes of <jats:italic>GSTM1<\/jats:italic> and <jats:italic>GSTT1<\/jats:italic> in order to investigate the association between them and the risk of developing essential hypertension.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a case-control study in Burkina Faso, including 245 subjects with essential hypertension as case and 269 control subjects with normal blood pressure. Presence of the <jats:italic>GSTT1<\/jats:italic> and <jats:italic>GSTM1<\/jats:italic> was determined using conventional multiplex polymerase chain reaction followed by gel electrophoresis analysis. Biochemical parameters were measured using chemistry analyzer CYANExpert 130.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Chi-squared test shows that <jats:italic>GSTT1-null<\/jats:italic> (OR\u2009=\u20091.82; <jats:italic>p<\/jats:italic>\u2009=\u20090.001) and <jats:italic>GSTM1-active\/GSTT1-null<\/jats:italic> genotypes (OR\u2009=\u20092.33; <jats:italic>p<\/jats:italic>\u2009&lt;\u2009\u00a00.001) were significantly higher in cases than controls; the differences were not significant for <jats:italic>GSTM1<\/jats:italic>-<jats:italic>null<\/jats:italic>, <jats:italic>GSTM1<\/jats:italic>-<jats:italic>null<\/jats:italic>\/<jats:italic>GSTT1-active<\/jats:italic> and <jats:italic>GSTM1-null<\/jats:italic>\/<jats:italic>GSTT1-null<\/jats:italic> (<jats:italic>p<\/jats:italic>\u2009&gt;\u20090.05). Multinomial logistic regression revealed that age\u2009\u2265\u200950\u2009years, central obesity, family history of hypertension, obesity, alcohol intake and <jats:italic>GSTT1<\/jats:italic> deletion were in decreasing order independent risk factors for essential hypertension. Analysis by gender, BMI and alcohol showed that association of <jats:italic>GSTT1<\/jats:italic>-null with risk of essential hypertension seems to be significant when BMI\u2009&lt;\u200930 Kg\/m<jats:sup>2<\/jats:sup>, in non-smokers and in alcohol users (all OR\u2009\u2265\u20091.77; <jats:italic>p<\/jats:italic>\u2009\u2264\u20090.008). Concerning <jats:italic>GSTT1<\/jats:italic>, <jats:italic>GSTM1<\/jats:italic> and cardiovascular risk markers levels in hypertensive group, we found that subjects with <jats:italic>GSTT1-null<\/jats:italic> genotype had higher waist circumference and higher HDL cholesterol level than those with <jats:italic>GSTT1-active<\/jats:italic> (all <jats:italic>p<\/jats:italic>\u2009&lt;\u2009\u00a00.005), subjects with <jats:italic>GSTM1-null<\/jats:italic> genotype had lower triglyceride than those with <jats:italic>GSTM1<\/jats:italic>-<jats:italic>active<\/jats:italic> (<jats:italic>p<\/jats:italic>\u2009=\u20090.02) and subjects with the double deletion <jats:italic>GSTM1-null<\/jats:italic>\/<jats:italic>GSTT1-null<\/jats:italic> had higher body mass index, higher waist circumference and higher HDL cholesterol than those with <jats:italic>GSTM1<\/jats:italic>-<jats:italic>active<\/jats:italic>\/<jats:italic>GSTT1<\/jats:italic>-<jats:italic>active<\/jats:italic> genotype (all <jats:italic>p<\/jats:italic>\u2009=\u20090.01).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our results confirm that <jats:italic>GSTT1-null<\/jats:italic> genotype is significantly associated with risk of developing essential hypertension in Burkinabe, especially when BMI\u2009&lt;\u200930 Kg\/m<jats:sup>2<\/jats:sup>, in non-smokers and in alcohol users, and it showed that the double deletion <jats:italic>GSTM1-null<\/jats:italic>\/<jats:italic>GSTT1-null<\/jats:italic> genotypes may influence body lipids repartition.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12881-020-0990-9","type":"journal-article","created":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T02:02:18Z","timestamp":1584583338000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Glutathione S-transferase M1 and T1 genes deletion polymorphisms and risk of developing essential hypertension: a case-control study in Burkina Faso population (West Africa)"],"prefix":"10.1186","volume":"21","author":[{"given":"Herman Karim","family":"Sombi\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abel Pegdwend\u00e9","family":"Sorgho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas Koudougou","family":"Kologo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9767-0646","authenticated-orcid":false,"given":"Abdoul Karim","family":"Ouattara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakinata","family":"Yam\u00e9ogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert Th\u00e9ophane","family":"Yonli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florencia Wendkuuni","family":"Djigma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dam\u00e9han","family":"Tchelougou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dogfounianalo","family":"Somda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle Touwendpoulimd\u00e9","family":"Kiendr\u00e9b\u00e9ogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prosper","family":"Bado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bolni Marius","family":"Nagalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youssoufou","family":"Nagabila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enagnon Ti\u00e9moko Herman Donald","family":"Adoko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrice","family":"Zabsonr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassanata","family":"Millogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Simpor\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,19]]},"reference":[{"issue":"6","key":"990_CR1","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1097\/HJH.0000000000000930","volume":"34","author":"J Redon","year":"2016","unstructured":"Redon J, Tellez-Plaza M, Orozco-Beltran D, Gil-Guillen V, Pita Fernandez S, Navarro-Perez J, Pallares V, Valls F, Fernandez A, Perez-Navarro AM, et al. Impact of hypertension on mortality and cardiovascular disease burden in patients with cardiovascular risk factors from a general practice setting: the ESCARVAL-risk study. J Hypertens. 2016;34(6):1075\u201383.","journal-title":"J Hypertens"},{"issue":"9623","key":"990_CR2","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0140-6736(08)60655-8","volume":"371","author":"CM Lawes","year":"2008","unstructured":"Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371(9623):1513\u20138.","journal-title":"Lancet"},{"issue":"9455","key":"990_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0140-6736(05)17741-1","volume":"365","author":"PM Kearney","year":"2005","unstructured":"Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, She J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217\u201323.","journal-title":"Lancet"},{"issue":"1","key":"990_CR4","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12889-016-3926-8","volume":"17","author":"JK Soubeiga","year":"2017","unstructured":"Soubeiga JK, Millogo T, Bicaba BW, Doulougou B, Kouanda S. Prevalence and factors associated with hypertension in Burkina Faso: a countrywide cross-sectional study. BMC Public Health. 2017;17(1):64.","journal-title":"BMC Public Health"},{"issue":"3","key":"990_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1161\/01.CIR.101.3.329","volume":"101","author":"OA Carretero","year":"2000","unstructured":"Carretero OA, Oparil S. Essential hypertension. Part I: definition and etiology. Circulation. 2000;101(3):329\u201335.","journal-title":"Circulation"},{"issue":"9587","key":"990_CR6","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S0140-6736(07)61299-9","volume":"370","author":"FH Messerli","year":"2007","unstructured":"Messerli FH, Williams B, Ritz E. Essential hypertension. Lancet. 2007;370(9587):591\u2013603.","journal-title":"Lancet"},{"issue":"2","key":"990_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1053\/snep.2001.20942","volume":"21","author":"S Klahr","year":"2001","unstructured":"Klahr S. Urinary tract obstruction. Semin Nephrol. 2001;21(2):133\u201345.","journal-title":"Semin Nephrol"},{"issue":"3","key":"990_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0891-5849(02)00908-5","volume":"33","author":"R Rodrigo","year":"2002","unstructured":"Rodrigo R, Rivera G. Renal damage mediated by oxidative stress: a hypothesis of protective effects of red wine. Free Radic Biol Med. 2002;33(3):409\u201322.","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"990_CR9","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1097\/00004872-200206000-00036","volume":"20","author":"MP Stojiljkovic","year":"2002","unstructured":"Stojiljkovic MP, Lopes HF, Zhang D, Morrow JD, Goodfriend TL, Egan BM. Increasing plasma fatty acids elevates F2-isoprostanes in humans: implications for the cardiovascular risk factor cluster. J Hypertens. 2002;20(6):1215\u201321.","journal-title":"J Hypertens"},{"issue":"1","key":"990_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1089\/152308604771978381","volume":"6","author":"M Tanito","year":"2004","unstructured":"Tanito M, Nakamura H, Kwon YW, Teratani A, Masutani H, Shioji K, Kishimoto C, Ohira A, Horie R, Yodoi J. Enhanced oxidative stress and impaired thioredoxin expression in spontaneously hypertensive rats. Antioxid Redox Signal. 2004;6(1):89\u201397.","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"990_CR11","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1161\/01.HYP.0000138070.47616.9d","volume":"44","author":"RM Touyz","year":"2004","unstructured":"Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension. 2004;44(3):248\u201352.","journal-title":"Hypertension"},{"issue":"2","key":"990_CR12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.febslet.2005.12.049","volume":"580","author":"G Gavazzi","year":"2006","unstructured":"Gavazzi G, Banfi B, Deffert C, Fiette L, Schappi M, Herrmann F, Krause KH. Decreased blood pressure in NOX1-deficient mice. FEBS Lett. 2006;580(2):497\u2013504.","journal-title":"FEBS Lett"},{"issue":"2","key":"990_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s11906-010-0100-z","volume":"12","author":"AM Briones","year":"2010","unstructured":"Briones AM, Touyz RM. Oxidative stress and hypertension: current concepts. Curr Hypertens Rep. 2010;12(2):135\u201342.","journal-title":"Curr Hypertens Rep"},{"issue":"5","key":"990_CR14","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.cellsig.2012.01.008","volume":"24","author":"PD Ray","year":"2012","unstructured":"Ray PD, Huang B-W, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 2012;24(5):981\u201390.","journal-title":"Cell Signal"},{"issue":"1","key":"990_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12291-014-0446-0","volume":"30","author":"A Phaniendra","year":"2015","unstructured":"Phaniendra A, Jestadi DB, Periyasamy L. Free radicals: properties, sources, targets, and their implication in various diseases. Indian J Clin Biochem : IJCB. 2015;30(1):11\u201326.","journal-title":"Indian J Clin Biochem : IJCB"},{"key":"990_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev.pharmtox.45.120403.095857","volume":"45","author":"JD Hayes","year":"2005","unstructured":"Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol. 2005;45:51\u201388.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"3","key":"990_CR17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3109\/10409238809088226","volume":"23","author":"B Mannervik","year":"1988","unstructured":"Mannervik B, Danielson UH. Glutathione transferases--structure and catalytic activity. CRC critical reviews in biochemistry. 1988;23(3):283\u2013337.","journal-title":"CRC critical reviews in biochemistry"},{"key":"990_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/BF00038994","volume":"22","author":"H Itzhaki","year":"1993","unstructured":"Itzhaki H, Woodson W. Characterization of an ethylene-responsive glutathione S-transferase gene cluster in carnation. Plant Mol Biol. 1993;22:43\u201358.","journal-title":"Plant Mol Biol"},{"issue":"1","key":"990_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00280-014-2566-x","volume":"75","author":"S Singh","year":"2015","unstructured":"Singh S. Cytoprotective and regulatory functions of glutathione S-transferases in cancer cell proliferation and cell death. Cancer Chemother Pharmacol. 2015;75(1):1\u201315.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1\u20132","key":"990_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0027-5107(01)00206-8","volume":"482","author":"RC Strange","year":"2001","unstructured":"Strange RC, Spiteri MA, Ramachandran S, Fryer AA. Glutathione-S-transferase family of enzymes. Mutat Res. 2001;482(1\u20132):21\u20136.","journal-title":"Mutat Res"},{"issue":"3","key":"990_CR21","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1159\/000028396","volume":"61","author":"JD Hayes","year":"2000","unstructured":"Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology. 2000;61(3):154\u201366.","journal-title":"Pharmacology"},{"issue":"1\u20133","key":"990_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.toxlet.2003.12.042","volume":"149","author":"H Norppa","year":"2004","unstructured":"Norppa H. Cytogenetic biomarkers and genetic polymorphisms. Toxicol Lett. 2004;149(1\u20133):309\u201334.","journal-title":"Toxicol Lett"},{"issue":"7","key":"990_CR23","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1097\/HJH.0b013e3282fe1d67","volume":"26","author":"C Delles","year":"2008","unstructured":"Delles C, Padmanabhan S, Lee WK, Miller WH, McBride MW, McClure JD, Brain NJ, Wallace C, Marcano AC, Schmieder RE, et al. Glutathione S-transferase variants and hypertension. J Hypertens. 2008;26(7):1343\u201352.","journal-title":"J Hypertens"},{"issue":"6","key":"990_CR24","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.ejim.2009.06.003","volume":"20","author":"SS Bessa","year":"2009","unstructured":"Bessa SS, Ali EM, Hamdy SM. The role of glutathione S- transferase M1 and T1 gene polymorphisms and oxidative stress-related parameters in Egyptian patients with essential hypertension. Eur J Intern Med. 2009;20(6):625\u201330.","journal-title":"Eur J Intern Med"},{"issue":"1\u20132","key":"990_CR25","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cca.2008.09.017","volume":"399","author":"E Capoluongo","year":"2009","unstructured":"Capoluongo E, Onder G, Concolino P, Russo A, Santonocito C, Bernabei R, Zuppi C, Ameglio F, Landi F. GSTM1-null polymorphism as possible risk marker for hypertension: results from the aging and longevity study in the Sirente geographic area (ilSIRENTE study). Clin Chim Acta. 2009;399(1\u20132):92\u20136.","journal-title":"Clin Chim Acta"},{"issue":"11","key":"990_CR26","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1089\/gtmb.2010.0186","volume":"15","author":"PK Borah","year":"2011","unstructured":"Borah PK, Shankarishan P, Mahanta J. Glutathione S-transferase M1 and T1 gene polymorphisms and risk of hypertension in tea garden workers of north-East India. Genet Test Mol Biomarkers. 2011;15(11):771\u20136.","journal-title":"Genet Test Mol Biomarkers"},{"issue":"1\u20132","key":"990_CR27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s11010-011-0893-3","volume":"357","author":"R Polimanti","year":"2011","unstructured":"Polimanti R, Piacentini S, Lazzarin N, Re MA, Manfellotto D, Fuciarelli M. Glutathione S-transferase variants as risk factor for essential hypertension in Italian patients. Mol Cell Biochem. 2011;357(1\u20132):227\u201333.","journal-title":"Mol Cell Biochem"},{"issue":"18","key":"990_CR28","first-page":"1420","volume":"7","author":"R Wang","year":"2012","unstructured":"Wang R, Wang Y, Wang J, Yang K. Association of glutathione S-transferase T1 and M1 gene polymorphisms with ischemic stroke risk in the Chinese Han population. Neural Regen Res. 2012;7(18):1420\u20137.","journal-title":"Neural Regen Res"},{"issue":"8","key":"990_CR29","first-page":"479","volume":"14","author":"K Hussain","year":"2012","unstructured":"Hussain K, Salah N, Hussain S, Hussain S. Investigate the role of glutathione S Transferase (GST) polymorphism in development of hypertension in UAE population. Iran Red Crescent Med J. 2012;14(8):479\u201382.","journal-title":"Iran Red Crescent Med J"},{"key":"990_CR30","doi-asserted-by":"crossref","unstructured":"Rong S-L, Zhou X-D, Wang Z-K, Wang X-L, Wang Y-C, Xue C-S, Li B. Glutathione S-Transferase M1 and T1 polymorphisms and hypertension risk: an updated meta-analysis. J Hum Hypertens. 2018.","DOI":"10.1038\/s41371-018-0133-3"},{"issue":"1","key":"990_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000268018","volume":"56","author":"SH Lee","year":"2010","unstructured":"Lee SH, Park E, Park YK. Glutathione S-Transferase M1 and T1 polymorphisms and susceptibility to oxidative damage in healthy Korean smokers. Ann Nutr Metab. 2010;56(1):52\u20138.","journal-title":"Ann Nutr Metab"},{"issue":"33","key":"990_CR32","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, et al. 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021\u2013104.","journal-title":"Eur Heart J"},{"issue":"13","key":"990_CR33","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1161\/CIRCULATIONAHA.107.739714","volume":"117","author":"C Zhang","year":"2008","unstructured":"Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation. 2008;117(13):1658\u201367.","journal-title":"Circulation"},{"issue":"3","key":"990_CR34","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"SA Miller","year":"1988","unstructured":"Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"990_CR35","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1182\/blood.V89.5.1701","volume":"89","author":"CL Chen","year":"1997","unstructured":"Chen CL, Liu Q, Pui CH, Rivera GK, Sandlund JT, Ribeiro R, Evans WE, Relling MV. Higher frequency of glutathione S-transferase deletions in black children with acute lymphoblastic leukemia. Blood. 1997;89(5):1701\u20137.","journal-title":"Blood"},{"key":"990_CR36","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2147\/CIA.S158513","volume":"13","author":"I Liguori","year":"2018","unstructured":"Liguori I, Russo G, Curcio F, Bulli G, Aran L, Della-Morte D, Gargiulo G, Testa G, Cacciatore F, Bonaduce D, et al. Oxidative stress, aging, and diseases. Clin Interv Aging. 2018;13:757\u201372.","journal-title":"Clin Interv Aging"},{"issue":"1","key":"990_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/00008571-199802000-00011","volume":"8","author":"CM Masimirembwa","year":"1998","unstructured":"Masimirembwa CM, Dandara C, Sommers DK, Snyman JR, Hasler JA. Genetic polymorphism of cytochrome P4501A1, microsomal epoxide hydrolase, and glutathione S-transferases M1 and T1 in Zimbabweans and Venda of southern Africa. Pharmacogenetics. 1998;8(1):83\u20135.","journal-title":"Pharmacogenetics"},{"issue":"1","key":"990_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1097-0215(20000401)86:1<1::AID-IJC1>3.0.CO;2-I","volume":"86","author":"CP Wild","year":"2000","unstructured":"Wild CP, Yin F, Turner PC, Chemin I, Chapot B, Mendy M, Whittle H, Kirk GD, Hall AJ. Environmental and genetic determinants of aflatoxin-albumin adducts in the Gambia. Int J Cancer. 2000;86(1):1\u20137.","journal-title":"Int J Cancer"},{"issue":"9","key":"990_CR39","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1515\/CCLM.2002.167","volume":"40","author":"C Dandara","year":"2002","unstructured":"Dandara C, Sayi J, Masimirembwa CM, Magimba A, Kaaya S, De Sommers K, Snyman JR, Hasler JA. Genetic polymorphism of cytochrome P450 1A1 (Cyp1A1) and glutathione transferases (M1, T1 and P1) among Africans. Clin Chem Lab Med. 2002;40(9):952\u20137.","journal-title":"Clin Chem Lab Med"},{"issue":"6","key":"990_CR40","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1046\/j.1365-2125.2003.01786.x","volume":"55","author":"SI Hamdy","year":"2003","unstructured":"Hamdy SI, Hiratsuka M, Narahara K, Endo N, El-Enany M, Moursi N, Ahmed MSE, Mizugaki M. Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population. Br J Clin Pharmacol. 2003;55(6):560\u20139.","journal-title":"Br J Clin Pharmacol"},{"issue":"5\u20136","key":"990_CR41","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/03014460600907517","volume":"33","author":"S Ouerhani","year":"2006","unstructured":"Ouerhani S, Tebourski F, Slama MR, Marrakchi R, Rabeh M, Hassine LB, Ayed M, Elgaaied AB. The role of glutathione transferases M1 and T1 in individual susceptibility to bladder cancer in a Tunisian population. Ann Hum Biol. 2006;33(5\u20136):529\u201335.","journal-title":"Ann Hum Biol"},{"issue":"5","key":"990_CR42","doi-asserted-by":"publisher","first-page":"612","DOI":"10.2353\/jmoldx.2007.070030","volume":"9","author":"A Buchard","year":"2007","unstructured":"Buchard A, Sanchez JJ, Dalhoff K, Morling N. Multiplex PCR detection of GSTM1, GSTT1, and GSTP1 gene variants: simultaneously detecting GSTM1 and GSTT1 gene copy number and the allelic status of the GSTP1 Ile105Val genetic variant. J Mol Diagn : JMD. 2007;9(5):612\u20137.","journal-title":"J Mol Diagn : JMD"},{"issue":"Suppl 1","key":"990_CR43","doi-asserted-by":"publisher","first-page":"S408","DOI":"10.1016\/j.legalmed.2009.01.073","volume":"11","author":"J Fujihara","year":"2009","unstructured":"Fujihara J, Yasuda T, Iida R, Takatsuka H, Fujii Y, Takeshita H. Cytochrome P450 1A1, glutathione S-transferases M1 and T1 polymorphisms in Ovambos and Mongolians. Leg Med (Tokyo). 2009;11(Suppl 1):S408\u201310.","journal-title":"Leg Med (Tokyo)"},{"issue":"3","key":"990_CR44","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1590\/S1415-47572010005000059","volume":"33","author":"A Santovito","year":"2010","unstructured":"Santovito A, Burgarello C, Cervella P, Delpero M. Polymorphisms of cytochrome P450 1A1, glutathione s-transferases M1 and T1 genes in Ouangolodougou (northern Ivory Coast). Genet Mol Biol. 2010;33(3):434\u20137.","journal-title":"Genet Mol Biol"},{"issue":"2","key":"990_CR45","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s11033-010-0221-0","volume":"38","author":"S Piacentini","year":"2011","unstructured":"Piacentini S, Polimanti R, Porreca F, Martinez-Labarga C, De Stefano GF, Fuciarelli M. GSTT1 and GSTM1 gene polymorphisms in European and African populations. Mol Biol Rep. 2011;38(2):1225\u201330.","journal-title":"Mol Biol Rep"},{"key":"990_CR46","doi-asserted-by":"crossref","unstructured":"Kassogue Y, Quachouh M, Dehbi H, Quessar A, Benchekroun S, Nadifi S. Effect of interaction of glutathione S-transferases (T1 and M1) on the hematologic and cytogenetic responses in chronic myeloid leukemia patients treated with imatinib. Med Oncol. 2014;31, 47(7).","DOI":"10.1007\/s12032-014-0047-z"},{"issue":"1_supplement","key":"990_CR47","first-page":"782.788","volume":"25","author":"JH Han","year":"2011","unstructured":"Han JH, Lee HJ, Cho MR, Yun KE, Choi HJ, Kang M-H. Association between glutathione S-transferase (GST) M1 and T1 Polymorphisms and subclinical hypertension in Korean population. FASEB J. 2011;25(1_supplement):782.788.","journal-title":"FASEB J"},{"issue":"5","key":"990_CR48","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3109\/03014460.2014.968206","volume":"42","author":"S Abbas","year":"2015","unstructured":"Abbas S, Raza ST, Chandra A, Rizvi S, Ahmed F, Eba A, Mahdi F. Association of ACE, FABP2 and GST genes polymorphism with essential hypertension risk among a north Indian population. Ann Hum Biol. 2015;42(5):461\u20139.","journal-title":"Ann Hum Biol"},{"issue":"2","key":"990_CR49","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.bbrc.2006.12.019","volume":"353","author":"C Marinho","year":"2007","unstructured":"Marinho C, Alho I, Arduino D, Falcao LM, Bras-Nogueira J, Bicho M. GST M1\/T1 and MTHFR polymorphisms as risk factors for hypertension. Biochem Biophys Res Commun. 2007;353(2):344\u201350.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"990_CR50","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s13273-012-0025-5","volume":"8","author":"B-K Lee","year":"2012","unstructured":"Lee B-K, Lee SJ, Joo JS, Cho K-S, Kim NS, Kim H-J. Association of Glutathione S-transferase genes (GSTM1 and GSTT1) polymorphisms with hypertension in lead-exposed workers. Mol Cell Toxicol. 2012;8(2):203\u20138.","journal-title":"Mol Cell Toxicol"},{"issue":"7\u20138","key":"990_CR51","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.clinbiochem.2014.03.012","volume":"47","author":"D Petrovic","year":"2014","unstructured":"Petrovic D, Peterlin B. GSTM1-null and GSTT1-null genotypes are associated with essential arterial hypertension in patients with type 2 diabetes. Clin Biochem. 2014;47(7\u20138):574\u20137.","journal-title":"Clin Biochem"},{"issue":"11","key":"990_CR52","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/ajh.2010.172","volume":"23","author":"TA Kotchen","year":"2010","unstructured":"Kotchen TA. Obesity-related hypertension: epidemiology, pathophysiology, and clinical management. Am J Hypertens. 2010;23(11):1170\u20138.","journal-title":"Am J Hypertens"},{"issue":"5","key":"990_CR53","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1042\/CS20050271","volume":"111","author":"J Kune\u0161","year":"2006","unstructured":"Kune\u0161 J, Zicha J. Developmental windows and environment as important factors in the expression of genetic information: a cardiovascular physiologist's view. Clin Sci. 2006;111(5):295\u2013305.","journal-title":"Clin Sci"},{"key":"990_CR54","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/hr.2011.39","volume":"34","author":"E Schulz","year":"2011","unstructured":"Schulz E, Gori T, M\u00fcnzel T. Oxidative stress and endothelial dysfunction in hypertension. Hypertens Res. 2011;34:665.","journal-title":"Hypertens Res"},{"key":"990_CR55","doi-asserted-by":"crossref","first-page":"204800401666964","DOI":"10.1177\/2048004016669645","volume":"5","author":"HA Almoshabek","year":"2016","unstructured":"Almoshabek HA, Mustafa M, Al-Asmari MM, Alajmi TK, Al-Asmari AK. Association of glutathione S-transferase GSTM1 and GSTT1 deletion polymorphisms with obesity and their relationship with body mass index, lipoprotein and hypertension among young age Saudis. JRSM Cardiovasc Dis. 2016;5:2048004016669645.","journal-title":"JRSM Cardiovasc Dis"},{"issue":"5","key":"990_CR56","first-page":"673","volume":"44","author":"M Afrand","year":"2015","unstructured":"Afrand M, Bashardoost N, Sheikhha MH, Afkhami-Ardekani M. Association between glutathione S-Transferase GSTM1-T1 and P1 polymorphisms with metabolic syndrome in Zoroastrians in Yazd, Iran. Iran J Public Health. 2015;44(5):673\u201382.","journal-title":"Iran J Public Health"},{"issue":"3","key":"990_CR57","first-page":"856","volume":"6","author":"S Khalilzadeh","year":"2014","unstructured":"Khalilzadeh S, Afrand M, Froozan-Nia SK, Sheikhha MH. Evaluation of glutathione S-transferase T1 (GSTT1) deletion polymorphism on type 2 diabetes mellitus risk in a sample of Yazdian females in Yazd, Iran. Electron Physician. 2014;6(3):856\u201362.","journal-title":"Electron Physician"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-020-0990-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12881-020-0990-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-020-0990-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T00:28:17Z","timestamp":1616113697000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/s12881-020-0990-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,19]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["990"],"URL":"https:\/\/doi.org\/10.1186\/s12881-020-0990-9","relation":{},"ISSN":["1471-2350"],"issn-type":[{"value":"1471-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,19]]},"assertion":[{"value":"1 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present study has been approved by the National Ethics Committee for Health Research of Burkina Faso.CERS20186065, 6 June 2018, retrospectively registered. Free and written consent was obtained from all participants of this study. The anonymity and confidentiality of the patients were respected as stated in the IRB (Institutional Review Board) protocol.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}